Viola Previtali

Dr. Viola Previtali

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2019 in MedChemComm
Verified
Journal Article
Closed access
PDF file
JCJorge Peiró Cadahía
Jorge Peiró Cadahía
VPViola Previtali
Viola Previtali
NTNikolaj S. Troelsen
Nikolaj S. Troelsen
MCMads Clausen
Mads Clausen
A comprehensive review of ROS-activated produg strategies for targeted therapy, including state-of-the-art and future perspectives.

1 November 2019 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HUHussain Ullah
Hussain Ullah
VPViola Previtali
Viola Previtali
HMHelene B. Mihigo
Helene B. Mihigo
BTBrendan Twamley
Brendan Twamley
MRMuhammad Khawar Rauf
Muhammad Khawar Rauf
IRIsabel Rozas
Isabel Rozas

31 March 2018 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JCJorge Peiró Cadahía
Jorge Peiró Cadahía
JBJon Bondebjerg
Jon Bondebjerg
CHChristian A. Hansen
Christian A. Hansen
VPViola Previtali
Viola Previtali
AHAnders E. Hansen
Anders E. Hansen
MCMads Clausen
Mads Clausen

1 August 2018 in European Journal of Medicinal Chemistry
Verified
Journal Article
Open access
NANikolaj S. Andersen
Nikolaj S. Andersen
JCJorge Peiró Cadahía
Jorge Peiró Cadahía
VPViola Previtali
Viola Previtali
JBJon Bondebjerg
Jon Bondebjerg
CHChristian A. Hansen
Christian A. Hansen
MCMads Clausen
Mads Clausen
Methotrexate (MTX) is the standard of care in the treatment of rheumatoid arthritis (RA), a common autoimmune disease that is characterized by chronic inflammation in the synovial membrane of joints. Unfortunately, MTX suffers from high discontinuation rates due to a large variability in efficacy and, in particular, adverse effects. As inflammation is associated with elevated levels of reactive oxygen species (ROS) like H2O2, we propose to improve treatment through site-selective delivery of MTX to inflammatory tissue by use of a H2O2 sensitive MTX prodrug. To establish proof proof-of-concept, two novel H2O2 sensitive, thiazolidinone-based MTX prodrugs were synthesized and evaluated for this purpose. MTX-γ-thiazolidinone (MTX-γ-TZ) exhibited the most promising properties - good to high chemical and metabolic stability, excellent aqueous solubility, while being activated when subjected to patho-physiological concentrations of H2O2. In vivo, MTX-γ-TZ exhibited comparable efficacy to MTX in a murine collagen type II-induced arthritis (CIA) model while treated mice showed indications of reduced toxicity as their body weight decreased less towards the end of the study, compared to the MTX-treated group.

18 September 2018 in Plant and Cell Physiology
Verified
Journal Article
Closed access
PDF file
LBLuisa Bermúdez
Luisa Bermúdez
TPTalía del Pozo
Talía del Pozo
BLBruno Silvestre Lira
Bruno Silvestre Lira
FGFabiana de Godoy
Fabiana de Godoy
IBIrene Boos
Irene Boos
MRMagdalena Rossi
Magdalena Rossi
Tocopherols are non-polar compounds synthesized in the plastids, which function as major antioxidants of the plant cells and are essential in the human diet. Both the intermediates and final products of the tocopherol biosynthetic pathway must cross plastid membranes to reach their sites of action. So far, no protein with tocopherol binding activity has been reported in plants. Here, we demonstrated that the tomato SlTBP protein is targeted to chloroplasts and able to bind α-tocopherol. SlTBP-knockdown tomato plants exhibited reduced levels of tocopherol in both, leaves and fruits. Several tocopherol-deficiency phenotypes were apparent in the transgenic lines, such as alterations in photosynthetic parameters, dramatic distortion of thylakoid membranes and significant variations in the lipid profile. These results, along with the altered expression of genes related to photosynthesis, tetrapyrrole, lipid, isoprenoid, inositol/phosphoinositide and redox metabolisms suggest that SlTBP may act conducting tocopherol (or its biosynthetic intermediates) between the plastid compartments and/or at the interface between chloroplast-ER membranes, affecting inter-organellar lipid metabolism.

17 March 2023 in Cancers
Verified
Journal Article
Open access
PDF file
BBBeatrice Balboni
Beatrice Balboni
FRFrancesco Rinaldi
Francesco Rinaldi
VPViola Previtali
Viola Previtali
ACAndrea Ciamarone
Andrea Ciamarone
SGStefania Girotto
Stefania Girotto
ACAndrea Cavalli
Andrea Cavalli
In recent years, the RAD52 protein has been highlighted as a mediator of many DNA repair mechanisms. While RAD52 was initially considered to be a non-essential auxiliary factor, its inhibition has more recently been demonstrated to be synthetically lethal in cancer cells bearing mutations and inactivation of specific intracellular pathways, such as homologous recombination. RAD52 is now recognized as a novel and critical pharmacological target. In this review, we comprehensively describe the available structural and functional information on RAD52. The review highlights the pathways in which RAD52 is involved and the approaches to RAD52 inhibition. We discuss the multifaceted role of this protein, which has a complex, dynamic, and functional 3D superstructural arrangement. This complexity reinforces the need to further investigate and characterize RAD52 to solve a challenging mechanistic puzzle and pave the way for a robust drug discovery campaign.